Rigel Pharmaceuticals (RIGL) Current Leases: 2010-2025
Historic Current Leases for Rigel Pharmaceuticals (RIGL) over the last 10 years, with Sep 2025 value amounting to $594,000.
- Rigel Pharmaceuticals' Current Leases rose 27.47% to $594,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $594,000, marking a year-over-year increase of 27.47%. This contributed to the annual value of $285,000 for FY2024, which is 58.82% down from last year.
- Per Rigel Pharmaceuticals' latest filing, its Current Leases stood at $594,000 for Q3 2025, which was up 14.89% from $517,000 recorded in Q2 2025.
- In the past 5 years, Rigel Pharmaceuticals' Current Leases ranged from a high of $9.9 million in Q4 2021 and a low of $285,000 during Q4 2024.
- In the last 3 years, Rigel Pharmaceuticals' Current Leases had a median value of $517,000 in 2025 and averaged $540,545.
- Per our database at Business Quant, Rigel Pharmaceuticals' Current Leases tumbled by 94.59% in 2023 and then soared by 57.91% in 2024.
- Rigel Pharmaceuticals' Current Leases (Quarterly) stood at $9.9 million in 2021, then slumped by 88.55% to $1.1 million in 2022, then slumped by 38.92% to $692,000 in 2023, then crashed by 58.82% to $285,000 in 2024, then rose by 27.47% to $594,000 in 2025.
- Its Current Leases was $594,000 in Q3 2025, compared to $517,000 in Q2 2025 and $456,000 in Q1 2025.